Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 43 results.
User Information
Export Records
  1. 1.   Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350
  2. Joyce, M Gordon; Bu, Wei; Chen, Wei-Hung; Gillespie, Rebecca A; Andrews, Sarah F; Wheatley, Adam K; Tsybovsky,Yaroslav; Jensen, Jaime L; Stephens,Tyler; Prabhakaran, Madhu; Fisher, Brian E; Narpala, Sandeep R; Bagchi, Meghna; McDermott, Adrian B; Nabel, Gary J; Kwong, Peter D; Mascola, John R; Cohen, Jeffrey I; Kanekiyo, Masaru
  3. Immunity. 2025, Feb 11; 58(2): 295-308.e5. .
  1. 2.   Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells
  2. Bu, Wei; Kumar, Ashish; Board, Nathan L; Kim, JungHyun; Dowdell, Kennichi; Zhang, Shu; Lei, Yona; Hostal, Anna; Krogmann, Tammy; Wang,Yanmei; Pittaluga, Stefania; Marcotrigiano, Joseph; Cohen, Jeffrey I
  3. Immunity. 2024, Mar 12; 57(3): 559-573.e6.
  1. 3.   Immune cell phenotype and function patterns across the life course in individuals from rural Uganda
  2. Nalwoga, Angela; Nakibuule, Marjorie; Roshan,Romin; Kwizera Mbonye, Moses; Miley,Wendell; Whitby,Denise; Newton, Robert; Rochford, Rosemary; Cose, Stephen
  3. Frontiers in Immunology. 2024 15: 1356635.
  1. 4.   Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition
  2. Chen, Wei-Hung; Kim, JungHyun; Bu, Wei; Board, Nathan L; Tsybovsky,Yaroslav; Wang,Yanmei; Hostal, Anna; Andrews, Sarah F; Gillespie, Rebecca A; Choe, Misook; Stephens, Tyler; Yang, Eun Sung; Pegu, Amarendra; Peterson, Caroline E; Fisher, Brian E; Mascola, John R; Pittaluga, Stefania; McDermott, Adrian B; Kanekiyo, Masaru; Joyce, M Gordon; Cohen, Jeffrey I
  3. Immunity. 2022, Nov 8; 55(11): 2135-2148.
  1. 5.   Identifying and characterizing virus-encoded circular RNAs
  2. Tagawa, Takanobu; Kopardé, Vishal N; Ziegelbauer, Joseph M
  3. Methods (San Diego, Calif.). 2021, Dec; 196: 129-137.
  1. 6.   Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV
  2. Kim, JungHyun; Bu, Wei; Mine, Sohtaro; Tariq, Zeshan; Nguyen, Hanh; Wang,Yanmei; Tolman, Cynthia; Mond, James; Cohen, Jeffrey I.
  3. VIROLOGY. 2021, Sep; 561: 80-86.
  1. 7.   Treatment of HIV-associated Primary CNS Lymphoma with Antiretroviral Therapy, Rituximab, and High-Dose Methotrexate
  2. Lurain, Kathryn; Uldrick, Thomas S; Ramaswami, Ramya; Polizzotto, Mark; Goncalves, Priscila; Widell, Anaida; Steinberg, Seth M; Jaffe, Elaine S; Pittaluga, Stefania; Wang, Hao-Wei; Yuan, Constance; Tamula,Mary Anne; Martin, Staci; Wolters, Pamela L; George, Jomy; Little, Richard F; Yarchoan, Robert
  3. Blood. 2020, NOV 5; 136(19): 2229-2232.
  1. 8.   Patients with NK cell chronic active EBV have immature NK cells and hyperactivation of PI3K/Akt/mTOR and STAT1 pathways
  2. Howe, Matthew K; Dowdell, Kennichi; Kuehn, Hye Sun; Li, Qingxue; Hart, Geoffrey T; Garabedian, Doreen; Liepshutz,Kelly; Hsu, Amy P; Su, Hua; Niemela, Julie E; Stoddard, Jennifer L; Uzel, Gulbu; Shereck, Evan; Schulz, Laura; Feldman, Tatyana; Rosenzweig, Sergio D; Long, Eric O; Dropulic, Lesia; Cohen, Jeffrey I
  3. The Journal of infectious diseases. 2020, OCT 1; 222(7): 1170-1179.
  1. 9.   Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma
  2. Zhu, Shanli; Chen, Jun; Xiong, Yirong; Kamara, Saidu; Gu, Meiping; Tang, Wanlin; Chen, Shao; Dong, Haiyan; Xue, Xiangyang; Zheng,Zhi-Ming; Zhang, Lifang
  3. PLoS pathogens. 2020, Jan 06; 16(1): e1008223.
  1. 10.   Epstein-Barr virus load is higher in long-term Hodgkin lymphoma survivors compared to their unaffected twins and unrelated controls
  2. Hwang, Amie E; Marshall, Vickie; Conti, David V; Nathwani, Bharat N; Mack, Thomas M; Whitby, Denise; Cozen, Wendy
  3. British Journal of Haematology. 2019, APR; 185(2): 377-380.
  1. 11.   Impaired Control of Epstein Barr Virus Infection in B-Cell Expansion with NF-kappa B and T-Cell Anergy Disease
  2. Arjunaraja, Swadhinya; Angelus, Pam; Su, Helen C.; Snow, Andrew L.
  3. FRONTIERS IN IMMUNOLOGY. 2018, Feb 8; 9
  1. 12.   Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda
  2. Juan, Ravell; Otim, Isaac; Nabalende, Hadijah; Legason, Ismail D; Reynolds, Steven J; Ogwang, Martin D; Ndugwa, Christopher M; Marshall, Vickie; Whitby, Denise; Goedert, Jim; Engels, Eric A; Bhatia, Kishor; Lenardo, Michael J; Mbulaiteye, Sam M
  3. Cancer Epidemiology. 2018, Feb; 52: 70-74.
  1. 13.   Whole-genome association study of antibody response to Epstein-Barr virus in an African population: a pilot
  2. Sallah, N; Carstensen, T; Wakeham, K; Beyer, Rachel; Labo, Nazzarena; Pollard, M O; Gurdasani, D; Ekoru, K; Pomilla, C; Young, E H; Fatumo, S; Asiki, G; Kamali, A; Sandhu, M; Kellam, P; Whitby, Denise; Barroso, I; Newton, R
  3. Global Health, Epidemiology and Genomics. 2017, Nov 27; 2: e18.
  1. 14.   Resolution of Multifocal Epstein-Barr Virus-Related Smooth Muscle Tumor in a Patient with GATA2 Deficiency Following Hematopoietic Stem Cell Transplantation
  2. Parta, Mark; Cuellar-Rodriguez, Jennifer; Freeman, Alexandra F; Gea-Banacloche, Juan; Holland, Steven M; Hickstein, Dennis D
  3. Journal of clinical immunology. 2017, Jan; 37(1): 61-66.
  1. 15.   Age of Infection and Risk of Virally Associated Cancers: New Clues to an Old Puzzle
  2. Bagni, R.; Whitby, D.
  3. Journal of Infectious Diseases. 2012, Mar; 205(6): 873-874.
  1. 16.   Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study
  2. Benavente, Y.; Mbisa, G.; Labo, N.; Casabonne, D.; Becker, N.; Maynadie, M.; Foretova, L.; Cocco, P. L.; Nieters, A.; Staines, A.; Bofetta, P.; Brennan, P.; Whitby, D.; de Sanjose, S.
  3. British Journal of Cancer. 2011, Nov; 105(11): 1768-1771.
  1. 17.   Quantitative Comparison of HTLV-1 and HIV-1 Cell-to-Cell Infection with New Replication Dependent Vectors
  2. Mazurov, D.; Ilinskaya, A.; Heidecker, G.; Lloyd, P.; Derse, D.
  3. Plos Pathogens. 2010, Feb; 6(2): 11.
  1. 18.   Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China
  2. Guo, X. C.; Johnson, R. C.; Deng, H.; Liao, J.; Guan, L.; Nelson, G. W.; Tang, M. Z.; Zheng, Y. M.; de The, G.; O'Brien, S. J.; Winkler, C. A.; Zeng, Y.
  3. International Journal of Cancer. 2009 124(12): 2942-2947.
  1. 19.   Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan
  2. Yu, K. J.; Gao, X. J.; Chen, C. J.; Yang, X. H.; Diehl, S. R.; Goldstein, A.; Hsu, W. L.; Liang, X. Y.; Marti, D.; Liu, M. Y.; Chen, J. Y.; Carrington, M.; Hildesheim, A.
  3. Human Immunology. 2009 70(11): 910-914.
  1. 20.   Cell proliferation and survival induced by toll-like receptors is antagonized by type IIFNs
  2. Hasan, U. A.; Caux, C.; Perrot, I.; Doffin, A. C.; Menetrier-Caux, C.; Trinchieri, G.; Tommasino, M.; Vlach, J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, May; 104(19): 8047-8052.
  1. 21.   PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes
  2. Robinson-White, A. J.; Leitner, W. W.; Aleem, E.; Kaldis, P.; Bossis, I.; Stratakis, C. A.
  3. Cancer Research. 2006, Nov; 66(21): 10603-10612.
  1. 22.   Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host
  2. Mbulaiteye, S.; Marshall, V.; Bagni, R. K.; Wang, C. D.; Mbisa, G.; Bakaki, P. M.; Owor, A. M.; Ndugwa, C. M.; Engels, E. A.; Katongole-Mbidde, E.; Biggar, R. J.; Whitby, D.
  3. Journal of Infectious Diseases. 2006, May; 193(9): 1250-1257.
  1. 23.   Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan
  2. Yang, X. H. R.; Goldstein, A. M.; Chen, C. J.; Rabkin, C. S.; Chen, J. Y.; Cheng, Y. J.; Hsu, W. L.; Sun, B.; Diehl, S. R.; Liu, M. Y.; Walters, M.; Shao, W.; Ortiz-Conde, B. A.; Whitby, D.; Elmore, S. H.; Gulley, M. L.; Hildesheim, A.
  3. International Journal of Cancer. 2006, MAR 1; 118(3): 780-784.
  1. 24.   High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs
  2. Mbulaiteye, S. M.; Walters, M.; Engels, E. A.; Bakaki, P. M.; Ndugwa, C. M.; Owor, A. M.; Goedert, J. J.; Whitby, D.; Biggar, R. J.
  3. Journal of Infectious Diseases. 2006, FEB 1; 193(3): 422-426.
  1. 25.   Latent membrane protein 1 encoded by Epstein-Barr virus modulates directly and synchronously cyclin D1 and p16 by newly forming a c-Jun/Jun B heterodimer in nasopharyngeal carcinoma cell line
  2. Song, X.; Tao, Y. G.; Zeng, L.; Deng, X. Y.; Lee, L. M.; Gong, J. P.; Wu, Q.; Cao, Y.
  3. Virus Research. 2005, NOV; 113(2): 89-99.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel